Reference : Les traitements cibles dans l'asthme: confirmations, espoirs et deceptions.
Scientific journals : Article
Human health sciences : Cardiovascular & respiratory systems
http://hdl.handle.net/2268/133660
Les traitements cibles dans l'asthme: confirmations, espoirs et deceptions.
French
[en] [Targeted asthma therapies: confirmations, hopes, and disappointments].
SCHLEICH, FLorence mailto [> >]
LOUIS, Renaud mailto [Centre Hospitalier Universitaire de Liège - CHU > > Pneumologie-Allergologie >]
2012
Revue Médicale de Liège
67 Spec No
14-21
Yes (verified by ORBi)
National
0370-629X
Belgium
[en] Anti-Asthmatic Agents/therapeutic use ; Antibodies, Monoclonal, Humanized/therapeutic use ; Asthma/drug therapy ; Humans ; Immunoglobulin E/immunology ; Interleukins/antagonists & inhibitors ; Tumor Necrosis Factor-alpha/antagonists & inhibitors
[en] Asthma is a chronic inflammatory disease of the airways. The inflammatory process is driven by different pathways involving cytokines and other protein mediators. Patients with severe asthma are at high risk of severe exacerbations and death and have few therapeutic options available. Therefore, biological agents have been developed to help patients with refractory asthma by interfering with several compounds of the asthma inflammatory cascade. In addition to decreasing exacerbations, some of those treatments have a steroid sparing role and many beneficial effects in asthmatics.
http://hdl.handle.net/2268/133660
http://www.rmlg.ulg.ac.be/

File(s) associated to this reference

Fulltext file(s):

FileCommentaryVersionSizeAccess
Open access
Les traitements ciblés dans l’asthme_confirmations espoirs et déceptions_Schleich_12_RevMedLG.pdfPublisher postprint235.98 kBView/Open

Bookmark and Share SFX Query

All documents in ORBi are protected by a user license.